Cardiovascular magnetic resonance physics for clinicians: Part II

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Biglands, John D ^a,c   Radjenovic, Aleksandra ^a,b   Ridgway, John P ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Coronary heart disease; Fat suppression; Late gadolinium enhancement; MR angiography; MR contrast agents; MR physics; Myocardial edema; Myocardial infarction; Myocardial ischemia; Myocardial perfusion imaging; Tagging; Velocity mapping

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADIPOSE TISSUE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; HEART MUSCLE BLOOD FLOW; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; RADIATION PHYSICS; REVIEW; SIGNAL NOISE RATIO; VELOCITY; ARTIFACT; BREATHING MECHANICS; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ARTIFACTS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; CORONARY CIRCULATION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATORY MECHANICS;

MLCS; MLOWN;

EID: 84866510419     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-66     Document Type: Review

References (109)

1. Cardiac magnetic resonance physics for clinicians: part I. Ridgway JP, J Card Magn Reson 2010 12 1 71 10.1186/1532-429X-12-71
2. Bogaert J, Dymarkowski S, Taylor A, Clinical Cardiac MR London: Springer 2005
3. Lee VS, Cardiovascular MR: Physical principles to practical protocols Philadelphia: Lippincott Williams and Wilkins 2005
4. McGee K, Williamson E, Julsrud P, Mayo Clinic Guide to Cardiac Magnetic Resonance Imaging Rochester: Mayo Clinic Scientific Press 2008
5. Biederman RWW, Doyle M, Yamrozik J, Cardiovascular MR Tutorial: Lectures and Learning Philadelphia: Lippincott Williams and Wilkins 2008
6. Grizzard JD, Judd RM, Kim RJ, Cardiovascular MR in Practice: A teaching file approach London: Springer 2008
7. Manning WJ, Pennell DJ, Cardiovascular Magnetic Resonance Philadelphia: Saunders 2 2010
8. Myerson SG, Francis JM, Neubauer S, Clinical Cardiac MR Oxford: Oxford University Press 2010
9. Plein S, Greenwood JP, Ridgway JP, Cardiovascular MR Manual London: Springer 2011
10. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Simonetti OP, Finn JP, White RD, Laub G, Henry DA, Radiology 1996 199 1 49 57 8633172
11. Value of fat suppression in the MRI evaluation of suspected arrhythmogenic right ventricular dysplasia. Abbara S, Migrino RQ, Sosnovik DE, Leichter JA, Brady TJ, Holmvang G, AJR Am J Roentgenol 2004 182 3 587 91 14975951
12. Myocardial tissue tagging with cardiovascular magnetic resonance. Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JAC, J Card Magn Reson 2009 11 55 10.1186/1532-429X-11-55
13. Myocardial tagging by Cardiovascular Magnetic Resonance: evolution of techniques-pulse sequences, analysis algorithms, and applications. Ibrahim E-SH, J Card Magn Reson 2011 13 1 36 10.1186/1532-429X-13-36
14. Cardiovascular magnetic resonance contrast agents. Caravan P, Cardiovascular Magnetic Resonance Philadelphia: Saunders, Manning WJ, Pennell DJ, 2010 76 90
15. Imaging sequences for first pass perfusion -a review. Kellman P, Arai AE, J Card Magn Reson 2007 9 3 525 37 10.1080/10976640601187604
16. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL, J Card Magn Reson 2008 18 10 1 18
17. An Improved MR Imaging Technique for the Visualization of Myocardial Infarction. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JMM, Finn JP, Judd RM, Radiology 2001 218 1 215 23 11152805
18. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim R, Fieno D, Parrish T, Harris K, Chen E, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226
19. Magnetic resonance angiography: current status and future directions. Hartung MP, Grist TM, François CJ, J Card Magn Reson 2011 13 1 19 10.1186/1532-429X-13-19
20. Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. Stuber M, Botnar RM, Danias PG, Sodickson DK, Kissinger KV, Van Cauteren M, De Becker J, Manning WJ, J Am Coll Cardiol 1999 34 2 524 31 10.1016/S0735-1097(99)00223-5 10440168
21. Coronary artery imaging methods. Nezefat R, Botnar RM, Kissinger KV, Hu F, Manning WJ, Cardiovascular Magnetic Resonance Philadelphia: Saunders, Manning WJ, Pennell DJ, 2010 284 99
22. Direct cardiac NMR imaging of heart wall and blood flow velocity. Van Dijk P, J Comput Assist Tomogr 1984 8 3 429 36 10.1097/00004728-198406000-00012 6725689
23. Cardiovascular Flow Measurement with Phase-Contrast MR Imaging: Basic Facts and Implementation. Lotz J, Meier C, Leppert A, Galanski M, Radiographics 2002 22 3 651 12006694
24. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Gatehouse PD, Keegan J, Crowe LA, Masood S, Mohiaddin RH, Kreitner K-F, Firmin DN, Eur Radiol 2005 15 10 2172 84 10.1007/s00330-005-2829-3 16003509
25. K-space in the clinic. Paschal CB, Morris HD, J Magn Reson Imaging 2004 19 2 145 59 10.1002/jmri.10451 14745747
26. MR Sequence Parameter Optimization: An Algorithmic Approach. Bradley WG, Tsuruda JS, AJR Am J Roentgenol 1987 149 4 815 23 3498335
27. A perspective on k-space. Mezrich R, Radiology 1995 195 297 315 7724743
28. Parallel MR Imaging: A User ' s Guide. Glockner JF, Hu HH, Stanley DW, Angelos L, King K, Radiographics 2005 25 1279 97 10.1148/rg.255045202 16160112
29. Implications of SENSE MR in routine clinical practice. van den Brink JS, Watanabe Y, Kuhl CK, Chung T, Muthupillai R, Van Cauteren M, Yamada K, Dymarkowski S, Bogaert J, Maki JH, Matos C, Casselman JW, Hoogeveen RM, Eur J Radiol 2003 46 1 3 27 10.1016/S0720-048X(02)00333-9 12648798
30. iPAT: applications for fast and cardiovascular MR imaging. Dietrich O, Nikolaou K, Wintersperger B, Flatz W, Nittka M, Petsch R, Kiefer B, Schoenberg S, Electromedica 2002 70 2 133 46
31. Four-dimensional single breathhold magnetic resonance imaging using kt-BLAST enables reliable assessment of left- and right-ventricular volumes and mass. Jahnke C, Nagel E, Gebker R, Bornstedt A, Schnackenburg B, Kozerke S, Fleck E, Paetsch I, J Magn Reson Imaging 2007 25 4 737 42 10.1002/jmri.20877 17347994
32. Real-time accelerated interactive MRI with adaptive TSENSE and UNFOLD. Guttman MA, Kellman P, Dick AJ, Lederman RJ, McVeigh ER, Magn Reson Med 2003 50 2 315 21 10.1002/mrm.10504 12876708
33. Fat suppression in MR imaging: techniques and pitfalls. Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A, Radiographics 1999 19 2 373 82 10194785
34. MR imaging: clinical use of the inversion recovery sequence. Bydder GM, Young IR, J Comput Assist Tomogr 1985 9 4 659 75 10.1097/00004728-198507010- 00002 2991345
35. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Hashemi RH, Bradley WG, Chen DY, Jordan JE, Queralt JA, Cheng AE, Henrie JN, Radiology 1995 196 2 505 10 7617868
36. 1 H NMR chemical shift selective (CHESS) imaging. Haase A, Frahm J, Hänicke W, Matthaei D, Phys Med Biol 1985 30 4 341 4 10.1088/0031-9155/30/ 4/008 4001160
37. MR imaging of motion with spatial modulation of magnetization. Axel L, Dougherty L, Radiology 1989 171 3 841 5 2717762
38. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Axel L, Dougherty L, Radiology 1989 172 2 349 50 2748813
39. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Grobner T, Nephrol Dial Transplant 2006 21 4 1104 8 16431890
40. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS, J Am Soc Nephrol 2006 17 9 2359 62 10.1681/ASN.2006060601 16885403
41. ACR guidance document for safe MR practices: 2007. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW, Nyenhuis J, Parag Y, Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L, Sass N, AJR Am J Roentgenol 2007 188 6 1447 74 10.2214/AJR.06.1616 17515363
42. Direct comparison of an intravascular and an extracellular contrast agent for quantifcation of myocardial perfusion. Jerosch-herold M, Wilke N, Wang Y, Gong G, Mansoor AM, Huang H, Gurchumelidze S, Stillman AE, Int J Card Imaging 1999 15 453 64 10.1023/A:1006368619112 10768740
43. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S, Lancet 2012 379 9814 453 60 10.1016/S0140-6736(11)61335-4 22196944
44. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Sourbron SP, Buckley DL, Phys Med Biol 2011 57 2 1 R33 22173205
45. Direct comparison of myocardial perfusion cardiovascular magnetic resonance sequences with parallel acquisition. Lyne JC, Gatehouse PD, Assomull RG, Smith GC, Kellman P, Firmin DN, Pennell DJ, J Magn Reson Imaging 2007 26 6 1444 51 10.1002/jmri.21167 17968886
46. Myocardial first pass perfusion: steady-state free precession versus spoiled gradient echo and segmented echo planar imaging. Wang Y, Moin K, Akinboboye O, Reichek N, Magn Reson Med 2005 54 5 1123 9 10.1002/mrm.20700 16217785
47. Multislice first-pass myocardial perfusion imaging: Comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. Fenchel M, Helber U, Simonetti OP, Stauder NI, Kramer U, Nguyen C-N, Finn JP, Claussen CD, Miller S, J Magn Reson Imaging 2004 19 5 555 63 10.1002/jmri.20050 15112304
48. MR artifacts: a review. Bellon EM, Haacke EM, Coleman PE, Sacco DC, Steiger DA, Gangarosa RE, AJR Am J roentgenol 1986 147 6 1271 81 3490763
49. An Image-based Approach to Understanding the Physics of MR Artifacts. Morelli J, Runge V, Fei A, Attenberger U, Vu L, Scmeets S, Nitz W, Kirsch J, Radiographics 2011 31 6 849 67 21571661
50. Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Professionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Sanjiv K, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 4 539 42 10.1161/hc0402.102975 11815441
51. Quantification of myocardial perfusion by cardiovascular magnetic resonance. Jerosch-Herold M, J Card Magn Reson 2010 12 1 57 10.1186/1532-429X- 12-57
52. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Di Bella EVR, Parker DL, Sinusas AJ, Magn Reson Med 2005 54 5 1295 9 10.1002/mrm.20666 16200553
53. Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study. Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgway JP, Sculpher M, Ball SG, Plein S, Trials 2009 10 62 10.1186/1745-6215-10-62 19640271
54. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E, Circulation 2003 108 4 432 7 10.1161/01.CIR.0000080915.35024.A9 12860910
55. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Büchi M, Knüsel PR, Marincek B, Lüscher TF, von Schulthess GK, Circulation 2001 103 18 2230 5 10.1161/01.CIR.103.18.2230 11342469
56. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. Costa MA, Shoemaker S, Futamatsu H, Klassen C, Anglolillo DJ, Nguyen M, Siuciak A, Gilmore P, Zenni MM, Guzman L, Bass TA, Wilke N, J Am Coll Cardiol 2007 50 6 514 22 10.1016/j.jacc.2007.04.053 17678734
57. Analysis of myocardial perfusion MRI. Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE, J Magn Reson Imaging 2004 19 6 758 70 10.1002/jmri.20065 15170782
58. Contrast-dose relation in first-pass myocardial MR perfusion imaging. Utz W, Niendorf T, Wassmuth R, Messroghli D, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 25 6 1131 5 10.1002/jmri.20910 17520736
59. Myocardial perfusion modeling using MRI. Larsson HBW, FritzHansen T, Rostrup E, Sondergaard L, Ring P, Henriksen O, Magn Reson Med 1996 35 5 716 26 10.1002/mrm.1910350513 8722823
60. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Fritz-Hansen T, Rostrup E, Larsson HB, Søndergaard L, Ring P, Henriksen O, Magn Reson Med 1996 36 2 225 31 10.1002/mrm.1910360209 8843376
61. Prebolus quantitative MR heart perfusion imaging. Köstler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J, Magn Reson Med 2004 52 2 296 9 10.1002/mrm.20160 15282811
62. Absolute quantification of myocardial perfusion under adenosine stress. Ritter C, Brackertz A, Sandstede J, Beer M, Hahn D, Kostler H, Magn Reson Med 2006 56 4 844 9 10.1002/mrm.21020 16941620
63. Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance. Gatehouse PD, Elkington AG, Ablitt N, Yang G-Z, Pennell DJ, Firmin DN, J Magn Reson Imaging 2004 20 1 39 45 10.1002/jmri.20054 15221807
64. Magnetic resonance first-pass myocardial perfusion imaging. Arai AE, Topics Magn Reson Imaging 2000 11 6 383 98 10.1097/00002142-200012000-00007
65. Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. Schreiber WG, Schmitt M, Kalden P, Mohrs OK, Kreitner K-F, Thelen M, J Magn Reson Imaging 2002 16 6 641 52 10.1002/jmri.10209 12451577
66. Comparison of hybrid echo-planar imaging and FLASH myocardial perfusion cardiovascular MR imaging. Elkington AG, Gatehouse PD, Cannell TM, Moon JC, Prasad SK, Firmin DN, Pennell DJ, Radiology 2005 235 1 237 43 10.1148/radiol.2351040360 15798172
67. Band artifacts due to bulk motion. Storey P, Chen Q, Li W, Edelman RR, Prasad PV, Magn Reson Med 2002 48 6 1028 36 10.1002/mrm.10314 12465113
68. Relationship of MRI Delayed Enhancement to Irreversible Injury, Infarct Age, and Contractile Function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002
69. Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM, Circulation 2001 104 10 1101 7 10.1161/hc3501.096798 11535563
70. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim R, Edwin W, Allen R, Enn-ling C, Parker M, Simonetti O, Klocke F, Bonow R, Judd R, N Engl J Med 2000 343 20 1445 53 10.1056/NEJM200011163432003 11078769
71. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur Heart J 2005 26 15 1461 74 10.1093/eurheartj/ehi258 15831557
72. Cardiovascular magnetic resonance in patients with myocardial infarction. Kim HW, Farzaneh-Far A, Kim RJ, J Am Col Card 2009 55 1 1 16 10.1016/j.jacc.2009.06.059
73. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim R, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 20 1445 53 10.1056/NEJM200011163432003 11078769
74. The " No-Reflow " Phenomenon after Temporary Coronary Occlusion in the Dog. Kloner RA, Ganote CE, Jennings RB, J Clin Invest 1974 54 1496 508 10.1172/JCI107898 4140198
75. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E, J Card Magn Reson 2007 9 4 653 8 10.1080/10976640601105614
76. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Kim RJ, Chen EL, Lima JA, Judd RM, Circulation 1996 94 12 3318 26 10.1161/01.CIR.94.12.3318 8989146
77. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S, Radjenovic A, Saha A, Greenwood JP, Plein S, J Card Magn Reson 2009 11 33 10.1186/1532-429X-11-33
78. Time Saving in Measurement of NMR and EPR Relaxation Times. Look DC, Rev Sci Instrum 1970 41 2 250 10.1063/1.1684482
79. Phase-Sensitive Inversion Phase-Sensitive Inversion Recovery for Detecting Myocardial Infarction Using Gadolinium-Delayed Hyperenhancement. Kellman P, Arai AE, Mcveigh ER, Aletras AH, Magn Reson Med 2002 383 372 83
80. Myocardial Viability: Assessment with Three-dimensional MR Imaging in Pigs and Patients. Dewey M, Laule M, Taupitz M, Kaufels N, Radiology 2006 239 3 703 9 10.1148/radiol.2393050586 16641341
81. Myocardial Viability: Breath-hold 3D MR Imaging of Delayed Hyperenhancement in Time. Foo TKF, Stanley DW, Castillo E, Rochitte CE, Wang Y, Bluemke DA, Wu KC, Radiology 2004 230 845 51 10.1148/radiol.2303021411 14990846
82. Fast, three-dimensional free-breathing MR imaging of myocardial infarction: a feasibility study. Saranathan M, Rochitte CE, Foo TKF, Magn Reson Med 2004 51 5 1055 60 10.1002/mrm.20061 15122690
83. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging. Nguyen TD, Spincemaille P, Weinsaft JW, Ho BY, Cham MD, Prince MR, Wang Y, J Magn Reson Imaging 2008 27 4 802 8 10.1002/jmri.21296 18302233
84. Multi-contrast delayed enhancement provides improved contrast between myocardial infarction and blood pool. Kellman P, Chung Y-C, Simonetti OP, McVeigh ER, Arai AE, J Magn Reson Imaging 2005 22 5 605 13 10.1002/jmri.20426 16215969
85. Enhanced viability imaging: improved contrast in myocardial delayed enhancement using dual inversion time subtraction. Foo TKF, Wolff SD, Gupta SN, Kraitchman DL, Magn Reson Med 2005 53 6 1484 9 10.1002/mrm.20515 15906286
86. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC, J Magn Reson Imaging 1993 3 6 877 81 10.1002/jmri.1880030614 8280977
87. Fast magnetic resonance angiography using turbo-FLASH sequences in advanced aortoiliac disease. Sivananthan UM, Ridgway JP, Bann K, Verma SP, Cullingworth J, Ward J, Rees MR, Br J Radiol 1993 66 792 1103 10 10.1259/0007-1285-66-792-1103 8293253
88. Postprocesing techniques for gadolinium enhanced three-dimensional MR angiography. Davis CP, Hany TF, Wildermuth S, Schmidt M, Debatin JF, RadioGraphics 1997 17 1061 77 9308101
89. Gadolinium enhanced MR aortography. Prince M, Radiology 1994 191 155 64 8134563
90. Contrast-Enhanced 3D MRA With Centric Ordering in k Space: A Preliminary Clinical Experience in Imaging the Abdominal Aorta and Renal and Peripheral Arterial Vasculature. Shetty AN, Bis KG, Vrachliotis TG, Kirsch M, Shirkhoda A, Ellwood R, J Magn Reson Imaging 1998 8 603 15 10.1002/jmri.1880080314 9626875
91. Performance of an elliptical centric view order for signal enhancement and motion artifact suppression in breath-hold three-dimensional gradient echo imaging. Wilman AH, Riederer SJ, Magn Reson Med 1997 38 5 793 802 10.1002/mrm.1910380516 9358454
92. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC, Radiology 1997 202 1 268 73 8988222
93. MR fluoroscopy: technical feasibility. Riederer SJ, Tasciyan T, Farzaneh F, Lee JN, Wright RC, Herfkens RJ, Magn Reson Med 1988 8 1 1 15 10.1002/mrm.1910080102 3173063
94. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries. Wilman AH, Riederer SJ, King BF, Debbins JP, Rossman PJ, Ehman RL, Radiology 1997 205 1 137 46 9314975
95. Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Foo TK, Saranathan M, Prince MR, Chenevert TL, Radiology 1997 203 1 275 80 9122407
96. Time-resolved contrast-enhanced 3D MR angiography. Korosec FR, Frayne R, Grist TM, Mistretta CA, Magn Reson Med 1996 36 3 345 51 10.1002/mrm.1910360304 8875403
97. Time-of-flight method of MR angiography. Laub GA, Magn Reson Imaging Clin N Am 1995 3 3 391 8 7584245
98. Non-contrast enhanced MR angiography: Established techniques. Miyazaki M, Akahane M, J Magn Reson Imaging 2012 35 1 1 19 10.1002/jmri.22789 22173999
99. Nonenhanced MR angiography. Miyazaki M, Lee VS, Radiology 2008 248 1 20 43 10.1148/radiol.2481071497 18566168
100. Phase contrast MR angiography techniques. Dumoulin CL, Magn Reson Imaging Clin N Am 1995 3 3 399 411 7584246
101. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J, Radiology 2003 227 3 890 6 10.1148/radiol.2273020227 12702824
102. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Botnar RM, Stuber M, Danias PGP, Kissinger KV, Manning WJ, Circulation 1999 99 24 3139 48 10.1161/01.CIR.99.24.3139 10377077
103. Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography. Sakuma H, Ichikawa Y, Suzawa N, Hirano T, Makino K, Koyama N, Van Cauteren M, Takeda K, Radiology 2005 237 1 316 21 10.1148/radiol.2371040830 16126921
104. Effects of turbulence on signal intensity in gradient echo images. Evans AJ, Blinder RA, Herfkens RJ, Spritzer CE, Kuethte DO, Fram EK, Hedlund LW, Kuethe DO, Invest Radiol 1988 23 7 512 8 10.1097/00004424-198807000-00006 3170139
105. Valvular heart disease. Kilner P, Mohiaddin R, Cardiovascular Magnetic Resonance Philadelphia: Saunders, Manning WJ, Pennell DJ, 2010 510 4
106. Blood flow velocity assessment. Firmin D, Cardiovascular Magnetic Resonance Philadelphia: Saunders, Manning WJ, Pennell D, 2010 91 9
107. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance images. Wagner S, Auffermann W, Buser P, Lim T, Kircher B, Plugfelder P, Higgins C, Am Heart J 1989 118 760 7 10.1016/0002-8703(89)90590-5 2801483
108. Cine MR imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. Suzuki J, Caputo GR, Kondo C, Higgins CB, AJR Am J Roentgenol 1990 155 4 723 7 2119099
109. Valve and great vessel stenosis: assessment with MR jet velocity mapping. Kilner PJ, Firmin DN, Rees RS, Martinez J, Pennell DJ, Mohiaddin RH, Underwood SR, Longmore DB, Radiology 1991 178 1 229 35 1984310